Cediranib may improve response rates in non-small-cell lung cancer
PIK3CA mutations linked to local recurrences of rectal cancer
Radical hysterectomy better than radiotherapy for early cervical cancer
Not all lymph node-positive bladder cancers carry poor prognosis
Trastuzumab prolongs survival in HER2+ metastatic breast cancer
Cetuximab renders inoperable colorectal liver metastases operable: study
Docetaxel, trastuzumab both improve survival in early breast cancer
Early PET-CT predicts treatment response of head and neck cancer
Radiation for early breast cancer: 3 weeks may be as good as 5 to 7